EGFR and disease of the tendon: Specifically, CTHRC1 interacts with EGFR and subsequently activates the MAPK signaling pathway to promote TSPC proliferation, migration, and tenogenic differentiation, thus promoting tendon regeneration and attenuating tendinopathy (Figure 8).